Lorazepam and Jentadueto drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lorazepam (lorazepam) and Jentadueto (linagliptin; metformin hydrochloride). Common drug interactions include abdominal discomfort among females and bacteraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Lorazepam and Jentadueto. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Lorazepam?

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,639 Lorazepam users. Check the latest studies of Lorazepam.

What is Jentadueto?

Jentadueto has active ingredients of linagliptin; metformin hydrochloride. eHealthMe is studying from 1,319 Jentadueto users. Check the latest studies of Jentadueto.

On Jul, 29, 2026

12 people who take Lorazepam and Jentadueto together, and have interactions are studied.

Lorazepam and Jentadueto drug interactions.

What are the common drug interactions of Lorazepam and Jentadueto, by gender? *:

female:

Abdominal discomfort
Arthralgia (joint pain)
Blood pressure increased
Chest pain
Diabetic foot infection
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Diarrhoea
Fatigue (feeling of tiredness)
Menstrual disorder (disease of menstrual cycle)
Myalgia (muscle pain)

male:

Bacteraemia (presence of bacteria in the blood)
Colitis (inflammation of colon)
Malaise (a feeling of general discomfort or uneasiness)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Pleural effusion (water on the lungs)
Febrile neutropenia (fever with reduced white blood cells)
Asthenia (weakness)
Cardiac disorder
Injection site extravasation (flow of (blood or lymph) from injection site)
Weight decreased

What are the common drug interactions of Lorazepam and Jentadueto, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Abdominal discomfort
Arthralgia (joint pain)
Blood pressure increased
Chest pain
Diabetic foot infection
Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
Diarrhoea
Fatigue (feeling of tiredness)
Menstrual disorder (disease of menstrual cycle)
Myalgia (muscle pain)

50-59:

n/a

60+:

Bacteraemia (presence of bacteria in the blood)
Colitis (inflammation of colon)
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Febrile neutropenia (fever with reduced white blood cells)
Asthenia (weakness)
Cardiac disorder
Injection site extravasation (flow of (blood or lymph) from injection site)
Weight decreased
Deafness
Haematuria (presence of blood in urine)

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma Recurrent (reoccurrence malignant (cancer) cells form in the lymph system): 6 people, 50.00%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 16.67%
Type 2 Diabetes: 1 person, 8.33%
Prostate Cancer: 1 person, 8.33%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 8.33%
Adenoid Cystic Carcinoma (cancer that can exist in many different body sites): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lorazepam and Jentadueto?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously